FIBRONOSTICS

Because Metabolic Health
Matters to All of Us

Visualizing the Invisible with LIVERFASt

What We Test:

Fibrosis

Activity

Steatosis

What You Get:

Screening

Staging

Monitoring

Our solutions are medical devices, developed with the help of artificial intelligence and advanced analytics. They have been validated by leading clinicians over many years and are easy-to-do. They help doctors and patients understand how their liver is doing without the need for expensive procedures.

What is LIVERFASt™?

LIVERFASt™ is a blood-based noninvasive test. It uses the input from 10 biomarkers and patient anthropometrics to generate and provide results using advanced analytics and a scoring system that has been developed over 10 years of research.

What does LIVERFASt™ Measure?

LIVERFASt™ uses the input from 10 biomarkers and patient anthropometrics to generate a score from 0.00 to 1.00. The score corresponds to the fibrosis, activity and steatosis staging, similar to a liver biopsy. In doing so, LIVERFASt™ provides high quality diagnostics information without the need for invasive procedures like a biopsy.

Fibrosis

STAGE

INTERPRETATION

FO

No fibrosis

F1

Mild fibrosis

F2

Advanced fibrosis

F1

Significant fibrosis

F4

Severe fibrosis/cirrhosis

Activity

STAGE

INTERPRETATION

aO

No activity

a1

Mild activity

a2

Moderate activity

a1

Marked activity

a4

Severe activity

Steatosis

STAGE

INTERPRETATION

sO

No steatosis (<5%)

s1

Mild steatosis(5-33%)

s2

Moderate steatosis(34-66%)

s3

Marked steatosis (≥ 67%)

LIVERFASt™ in Numbers

Over

tests conducted
0 million

Sold in

Countries
> 0

Adopted by

Doctors
> 0

Did you know?

MASH & MASLD (formerly known as NASH & NAFLD) are metabolic diseases of liver. MASLD and MASH can affect people of any age, including children. It is more common in people who live with certain conditions, including obesity (BMI >30) and conditions that may be related to obesity, such as type 2 diabetes, high blood pressure or cholesterol.

How it Works

LIVERFASt™ is easy to do. A simple blood draw from a patient is analyzed in Fibronostics’ CAP & CLIA certified laboratory. This ensures high and consistent of the data generation and analysis. Results are returned to the prescribing physician via our portal, physician’s EMR or other forms of integration.

Physician prescribes
LIVERFASt™

Lab analyzes
10 biomarkers from
1 blood draw

Biomarker values plus age,
height, weight, gender,
are
entered into the platform

LIVERFASt™ results
are available

Physician prescribes
LIVERFASt™

Lab analyzes
10 biomarkers from
1 blood draw

Biomarker values plus age,
height, weight, gender,
are
entered into the platform

LIVERFASt™ results
are available
immediately

Our Benefits

Fast and
Easy-to-do

Minimized
waiting time

Noninvasive

Only one blood draw
required to run our test

Accurate

Robust testing and
validation

Suitable for Multiple Care Settings

Suitable for both early to
late stage care

Benefits

Fast and
Easy-to-do

Minimized
waiting time

Noninvasive

Only one blood draw
required to run our test

Accurate

Robust testing and
validation

Suitable for Multiple Care Settings

Suitable for both early to
late stage care

Your Trusted Partner in Liver Health

When Quality Matters and Dependability Counts

Selected publications

Our
Certifications/
Reinbursement

Our
Platform

Our
Lab

Our
Partners

Discover LIVERFASt in an Informational Video

Brock Smith

CEO

Interested in LIVERFASt™?

Contact our sales representative to inquire more about LIVERFASt™ and how it can help you and your patients improve their liver health.

Our Videos

Let’s Keep in Touch!

Submit your email below to receive email updates
on events, new product releases and more!

For further inquiry, please contact us at: service@fibronostics.com
For clinical and medical enquiries, contact us at: medicalaffairs@fibronostics.com